Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
mrp, did he state why $15? Is that for what time period? End of June, July, August, September, 2024, 2025?
One would think that if it goes up ~300% that there were positive news and if so, that news moves it up more than ~300%.
george, 2014 is an agnostic if I remember correctly. He doesn't take off for Christmas, so why would he for the Ascension? 😉
Chris, as to disclosure, if partnerships are based on approval, do they need to be revealed before approval decision is received?
That you have been fired by your handlers, Ziggy.
plex, fda and EMA filings will occur at same time so Anavex doesn’t p/o fda. I’m thinking before Labor Day or thereabouts based on observations of other viewpoints on EMA filing.
Before that though, partnership with Consortium members or other BP will happen after ASM on June 18 but before Labor Day. IMO
Annual Meeting set for June 18.
https://www.sec.gov/Archives/edgar/data/1314052/000173112224000730/e5638_def14a.htm
What is with the new image include in PR? I don't like it.
P.S. The material matter causing the proxy delay might be the ambulance-chasers' lawsuit(s) against Anavex and how it needs to word that disclosure in the proxy and Q2 statement/filing.
JJ, we have not seen the proxy, which was issued on April 4th last year, seven weeks before the ASM. The proxy must be issued no less than 21 days before that meeting. Most companies give themselves, especially small ones, over a month before ASM, so it can gather enough votes to pass its slate of directors and other items being voted on by the shareholders. Thus, for Anavex to meet the May 23rd deadline you espouse is not late, the proxy would need to be filed by tomorrow with only a three-week allowance for shareholder voting, which would be contrary to pass Anavex ASM's and the respective voting.
What is in the works, I don't know if there were anything or not. We might see Q2 numbers next week if there were no material event(s) being considered ... and maybe, an explanation on the proxy/ASM for this year.
No, Joe, those are cicadas!
old*, there have been many posters on this MB that have advocated the same thing for years in different terms before this guy showed up with his "AI" generated type postings.
mrp, your analysis, please?
So, go avxl, by your review marks, this isn't the Anavex MB?
I thought this was the ANAVEX board!
P.S. I am wondering, after the Rett January numbers, which were better by ~ 3x than those of Acadia's, whether Dr. Missling, his staff, the lawyers, et al realized that Anavex was batting against Sandy Koufax with a whiffle ball bat and its strategy needed to be altered.
BP has many different ways to "influence" a trial and it wouldn't surprised me if it did here ... with the results, Dr. M understood that fact and is looking to bring in some heavy muscle, e.g., Merck, Takeda among others. Just a thought ...
Gary, this is not a NWBO scenario. Anavex will need to be forthcoming in the next two weeks as to its current situation. If not, it will need to be specific as to why no data is being revealed. If Anavex were still ambiguous, there will be more lawsuits directed at the withholding of material evidence, which might be easier to prove than the ambulance chasers as there are dates when data is known and whether it were disclosed or not.
Hopefully, in the next 7-10 days, this will all be clarified.
Gary, I don't know about the NWBO activities that you mentioned or its responsibilities to report, though several NWBO posters have been here in the past and have brought their complaints and/or optimism.
What I do know is that Anavex has a date of May 10th for Q2 numbers plus a CC and if it weren't released/conducted with some news on the ASM, our NYC shareholders would set up a date to meet in Manhattan and storm the Anavex offices. [My wife and I might join them from NW Indiana.] If a delay were announced and no valid reason provided, the stock gets hammered to pre-RS levels as it is easier to FUD then defend when that happens.
Therefore, Dr. Missling, give us something to hang our hats on in the next two weeks.
Bio4, if any of that were true as to your career, you would NOT be trolling any message board with your "best intentions." You would be long gone into a wealthy retirement and there would be no need to be here ...
Unless, you were a lousy management consultant and were not able to ID the right guy more often than not. Actually, given your posts over time on the Anavex board, that is probably the case ... and, you are missing again.
I pity your poor sign ... No, you probably don't have any one tied to you ... each one saw you for the loser you are!
John k9, a lot of people have been here since 2015 and we don't need to be reminded that you have been here since that year with every post you make ... nor that you are not leaving ... most of us from 2015 and before are not leaving either.
Peace,
powerwalker
plex, Q2 number should be issued by May 10th and usually a CC. As to whether that leads to real news, is anyone's guess.
A wrench might be thrown into this schedule since no ASM date has been announced nor proxy issued. If there were activities going on in the background, then Q2 numbers could be delayed, too.
Tred, do you have any of the details on the ANVS deal? Similar to Anavex's Lincoln Capital and their deal?
Thanks.
mrp, you do not know the strategic plan ... the Board does ... and it apparently approves of the plan as it has not let TGD go as of today.
They know the process and time line: Board, TGD and the officers/workers of Anavex. It appears no one important is jumping ship.
The plan is in incubation ... let it hatch.
sum, that is right … and I’m not sure Anavex has even filed a draft of it.
Something is cooking … I just don’t know if it is Dreamland ribs or stone soup!!
mike, I noted that last week that the proxy hasn't been filed. It is as if Anavex and TGD were waiting for something to happen ... I assume good since if it were bad, ASM would have been held by now, so the direct questions from shareholders would not have to be answered.
I think good news is coming soon ... even in The Chosen, the word "soon" is always under scrutiny! 😉
Peace, mike,
powerwalker
Thanks, george, for clarifying.
Hosai, check your numerals ... one too many or one too few.
Peace,
powerwalker
sum, when it was formed 5 years ago (ATH, please note, not "7"), Anavex was the principal driver to bring the original group of companies, which is why I've called it the "Anavex Consortium," regardless of the name established.
Obviously, with the new additions over the years, it has a stronger presence and I hope it has greater advancements in its future that will profit mankind ... and, of course, Anavex shareholders.
hnbadgers, the Consortium has added AbbVie, Astellas, Novartis and Neurocrine Biosciences. Sensational adds since the Consortium's start.
P.S. Wish they would all announce a buy of one million Anavex shares each ... including Anavex.
Good Ole Bill, Cognision is a member of the Anavex Consortium that includes Merck, Takeda, Lundbeck and Alkemes along with Sage Therapeutics and Cadent Therapeutics.
https://www.businesswire.com/news/home/20190320005368/en/Industry-Consortium-Launched-to-Qualify-Biomarkers-for-Schizophrenia-Drug-Development
IMO, good news as the Consortium is beginning to move.
mrp, maybe you should answer this?
Rather weak FUD attempt, 2014, as these two companies have been partners for a long time ... as you well know.
Plus, why would Anavex want to partner with Eisai after its partnership with Biogen?
00, you never owned anything ... well, maybe 1 share.
Gary, thanks for your thoughts on today's presentation.
Maybe, it is time to throw away one of those four years of cash and do a stock buy back of 5 million shares at the 2024 high ($6.94). I know that sounds irresponsible, but if you believe that, within three years, approval will be received for one indication (which indicates approval for other applications, too), then the cash will be there for whatever need there is in the future.
It is time to show the market that Anavex has some cojones and that it believes in its pipeline.
Actually, Doc, that is a good one. They know (and might be more worried about) that they can be sued for failure to perform their fiduciary duties, which means their options are worthless, there is no D&O insurance to protect them and they pay out-of-pocket $$$, big ones I might add, for legal defense ... and the friendships turn to hatred (personal experience on that one).
They aren't ready to ditch their friend because ... they know EVERYTHING that we DO NOT!
Blood (Money) is thicker than water (friendship).
Also, if a logic person had read all that the naysayers have written over the last few days and thought those posters were more correct than wrong, then s/he would claim that the BOD is stupid for not firing TGD. This BOD is not stupid ... they know the Anavex plan, 2-73 results and strategy ... and waiting for it to be revealed.
ATH, it is possible the BOD will not "man up" as you think it should because:
1) The members of the Board know the plan and the strategy going forward; you nor anyone on this board knows that.
2) The Board members have seen the full results of all the trials. They agree in principle with 1).
3) They are well aware of TGD's short-comings. His management of 1) and 2) over-rides that concern.
4) Tom Skarpelos is not afraid to pull the plug on a floundering CEO (see Missling's predecessor, Cameron Durrant). He is still in Dr. Missling's corner.
5) Naysayers' success of scaring posters to sell 10K, 50K or 100K over a week's time, is a win for lower prices and its benefactors and indicates a drug's failure. Only, the world's drug agencies will decide a drug's pass or fail. IMO, 2-73 will pass!
Funny, you only show up on beat-down days for this stock, along with several others.
Peace,
powerwalker
Thanks, William. Good to know.
ATH, I have been reading your posts since you came on the board 8-9 years ago. You were never "WGT" as you always had a cautious approach before turning negative.
Rightly or wrongly, I have been a "WGT" member ever since the first trial results of 2-73 were issued in 2015 that showed the "Strong Responders" improved, i.e., reversed their Alzheimer's Disease over the first 31 weeks and all 7 were not using Aricept/DPZ. Continued improvement for them strengthened that faith.
Other results with other diseases have shown 2-73 is better than placebos and current SOC's. So, I stay on the "WGT" side of the opinion line.
Peace,
powerwalker
Here is a status of AD bills in Congress, per my representative:
ATH, you were never WGT!
mrp, I understand what you were going thru last year with a West Point graduation around the same time as the ASM.
However,
Pleassssse!! Anavex numbers were almost 3X better than Acadia's. That we know along with good numbers for the placebo crowd that made p=.067, as opposed to the needed p<.05 that is the sacrosanct number. [If p were linear, a .1 difference in placebo group, might have hit .05.]
Given that, we know nothing else about the Rett trial. There were 77 out of 92 that finished the 2:1 trial and that is all. That is all we know! Most of the dropouts may have been placebo girls as the caretakers did not see any improvements and left the trial, so they could give their charges something, even if it were Acadia's drug.
I would like to think the delay in the ASM is due to waiting on Anavex's and TGD's parts as some newsworthy event might be on the horizon and the ASM is being held up for that. 🤞
But, mrp, on one of these ASM days, I do hope to meet you.
Peace,
powerwalker